The chatter around ALLO is a tug-of-war between AI-driven optimism and concentration concerns. Here’s what’s trending: Analysts are spotting bullish technical patterns, eyeing a breakout above $0.245.

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Allogene's new CEO Zachary Roberts outlined a strategic refocus on leveraging the intrinsic advantages of allogeneic (off-the-shelf) CAR-T — ready availability, consistent product quality, and ability ...

Allora's price outlook hinges on adoption versus token unlocks in a volatile AI-crypto niche. Adoption vs. Unlocks – Only ~20% of the 1B ALLO supply circulates, with major backer unlocks extending to ...

Ready to watch 'Allo 'Allo!? This 1984 Comedy/War & Politics series is available to watch right now. It's currently streaming on Amazon Prime Video, Peacock Premium, BritBox, Peacock Premium Plus, ...

Profound Medical Corp. is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the ablation of diseased tissue ...

Prof G Markets is your daily briefing on the news moving markets — from earnings and geopolitics, to Big Tech and AI. Hosted by Scott Galloway and Ed Elson, we cut through the noise with no-BS ...

The countdown is officially on to B2B Forum this November 2–4 in Boston! There's still time to get your magic ticket to experience over 60 sessions and workshops to get your 2027 marketing plan into ...